Exact Mass: 466.2692

Exact Mass Matches: 466.2692

Found 98 metabolites which its exact mass value is equals to given mass value 466.2692, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Acetildenafil

1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate

C25H34N6O3 (466.2692)


   

Mutant IDH1 inhibitor

3-{2-[(1-{4-[(4-acetylpiperazin-1-yl)methyl]phenyl}ethyl)amino]pyrimidin-4-yl}-4-(propan-2-yl)-1,3-oxazolidin-2-one

C25H34N6O3 (466.2692)


   

Ramiflorine A

Ramiflorine A

C30H34N4O (466.2732)


   

Kleinioxanthrone 2

Kleinioxanthrone 2

C29H38O5 (466.2719)


   

Chabrolonaphthoquinone B

Chabrolonaphthoquinone B

C29H38O5 (466.2719)


   

acetildenafil

acetildenafil

C25H34N6O3 (466.2692)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Acetylvardenafil

Acetylvardenafil

C25H34N6O3 (466.2692)


   

Dimethyl acetildenafil

Dimethyl acetildenafil

C25H34N6O3 (466.2692)


   

1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N2-methylalaninamide

1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N2-methylalaninamide

C23H38N4O6 (466.2791)


   

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-11-ol|Usambaridin Br|Usambaridine Br

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-11-ol|Usambaridin Br|Usambaridine Br

C30H34N4O (466.2732)


   

10-Hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-10-ol|18-Dehydro-10-hydroxynigritanin

10-Hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-10-ol|18-Dehydro-10-hydroxynigritanin

C30H34N4O (466.2732)


   

(11alpha,12alpha)-4-demethyl-11,12-epoxy-3,13-dihydroxy-2-oxoursa-3,20(30)-diene-28-oic acid gamma-lactone|adenanthusone

(11alpha,12alpha)-4-demethyl-11,12-epoxy-3,13-dihydroxy-2-oxoursa-3,20(30)-diene-28-oic acid gamma-lactone|adenanthusone

C29H38O5 (466.2719)


   

Withanicandrin

Withanicandrin

C29H38O5 (466.2719)


   

Isovaleryl-coladonin

Isovaleryl-coladonin

C29H38O5 (466.2719)


   

8alpha-hydroxylabda-13(16),14-dien-19-yl (Z)-4-hydroxycinnamate

8alpha-hydroxylabda-13(16),14-dien-19-yl (Z)-4-hydroxycinnamate

C29H38O5 (466.2719)


   

2,22beta-dihydroxy-3-methoxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione

2,22beta-dihydroxy-3-methoxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione

C29H38O5 (466.2719)


   

3-methyl-23-hydroxy-6-oxo-tingenol|3-O-methyl-23-hydroxy-6-oxotingenol

3-methyl-23-hydroxy-6-oxo-tingenol|3-O-methyl-23-hydroxy-6-oxotingenol

C29H38O5 (466.2719)


   
   

(11S,12S)-4-methyl-11,12-epoxy-2-hydroxy-3-oxoursa-1,4-dine-28-oic acid-gamma-lactone|ulmoidol A

(11S,12S)-4-methyl-11,12-epoxy-2-hydroxy-3-oxoursa-1,4-dine-28-oic acid-gamma-lactone|ulmoidol A

C29H38O5 (466.2719)


   

23-Nor-6-oxopristimerol

23-Nor-6-oxopristimerol

C29H38O5 (466.2719)


   

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-12-ol|Usambaridin Vi

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-12-ol|Usambaridin Vi

C30H34N4O (466.2732)


   

Wilforol A

(2R,4aS,6aS,12bR,14aS,14bR)-10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-8-oxo-1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid

C29H38O5 (466.2719)


Wilforol A is a pentacyclic triterpenoid with formula C29H38O5, originally isolated from the stems of Tripterygium regelii. It has a role as a plant metabolite. It is a pentacyclic triterpenoid, a hydroxy monocarboxylic acid, a member of catechols, a cyclic terpene ketone and an enone. Wilforol A is a natural product found in Tripterygium hypoglaucum, Tripterygium wilfordii, and Celastrus orbiculatus with data available. A pentacyclic triterpenoid with formula C29H38O5, originally isolated from the stems of Tripterygium regelii.

   

5??,6??-Epoxy-4??-hydroxy-1-oxo-witha-2,16,24-trienolide

5??,6??-Epoxy-4??-hydroxy-1-oxo-witha-2,16,24-trienolide

C29H38O5 (466.2719)


   

6-Oxo-23-norpristimerol

6-Oxo-23-norpristimerol

C29H38O5 (466.2719)


   

C23H38N4O6_1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N~2~-methylalaninamide

NCGC00381111-01_C23H38N4O6_1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N~2~-methylalaninamide

C23H38N4O6 (466.2791)


   

10-hydroxyusambarine

10-hydroxyusambarine

C30H34N4O (466.2732)


   

11-hydroxyusambarine

11-hydroxyusambarine

C30H34N4O (466.2732)


   

ST 29:7;O5

3-oxo-18-acetoxywitha-1,4,24-trienolide

C29H38O5 (466.2719)


   

3,3-(Ethane-1,2-diylbis(oxy))bis(3,1-phenylene)diboronic acid, pinacol ester

3,3-(Ethane-1,2-diylbis(oxy))bis(3,1-phenylene)diboronic acid, pinacol ester

C26H36B2O6 (466.2698)


   

N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,2-(chloromethyl)oxirane,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol

N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,2-(chloromethyl)oxirane,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol

C24H39ClN4O3 (466.2711)


   

5-S-[2-(Decylamino)ethyl]-5-Thioadenosine

5-S-[2-(Decylamino)ethyl]-5-Thioadenosine

C22H38N6O3S (466.2726)


   

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-10-ol

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-10-ol

C30H34N4O (466.2732)


   

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-9-ol

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-9-ol

C30H34N4O (466.2732)


   

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) decanoate

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) decanoate

C22H43O8P (466.2695)


   

2,3-dihydroxypropyl [3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hydroxypropyl] hydrogen phosphate

2,3-dihydroxypropyl [3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hydroxypropyl] hydrogen phosphate

C22H43O8P (466.2695)


   

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) hexadecanoate

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) hexadecanoate

C22H43O8P (466.2695)


   

(1-Acetyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

(1-Acetyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C22H43O8P (466.2695)


   

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

C22H43O8P (466.2695)


   

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) undecanoate

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) undecanoate

C22H43O8P (466.2695)


   

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate

C22H43O8P (466.2695)


   

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) dodecanoate

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) dodecanoate

C22H43O8P (466.2695)


   

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

C22H43O8P (466.2695)


   

N-[(E,4Z,7R)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2H-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-enyl]-N-methylacetamide

N-[(E,4Z,7R)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2H-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-enyl]-N-methylacetamide

C25H39ClN2O4 (466.2598)


   
   
   
   
   
   

LPG P-16:1 or LPG O-16:2

LPG P-16:1 or LPG O-16:2

C22H43O8P (466.2695)


   
   

LP-211

LP-211

C30H34N4O (466.2732)


LP-211 is a selective and blood?brain barrier penetrant 5-HT7 receptor agonist, with a Ki of 0.58 nM, with high selectivity over 5-HT1A receptor (Ki, 188 nM) and D2 receptor (Ki, 142 nM).

   

Mutant IDH1 inhibitor

Mutant IDH1 inhibitor

C25H34N6O3 (466.2692)


Mutant IDH1 inhibitor is a potent mutant IDH1 R132H inhibitor with IC50 of < 72 nM.

   

6-hydroxy-2,6,10-trimethyl-13-(7-methyl-5,8-dioxonaphthalen-2-yl)trideca-2,10-dien-7-yl acetate

6-hydroxy-2,6,10-trimethyl-13-(7-methyl-5,8-dioxonaphthalen-2-yl)trideca-2,10-dien-7-yl acetate

C29H38O5 (466.2719)


   

6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl 3-(4-hydroxyphenyl)prop-2-enoate

6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H38O5 (466.2719)


   

methyl 2-(5-hydroxy-2-{[(6e)-3-methyl-7-{[(1r,5r)-3-methyl-5-(2-methylprop-1-en-1-yl)-4-oxocyclopent-2-en-1-yl]methyl}octa-1,6-dien-3-yl]oxy}phenyl)acetate

methyl 2-(5-hydroxy-2-{[(6e)-3-methyl-7-{[(1r,5r)-3-methyl-5-(2-methylprop-1-en-1-yl)-4-oxocyclopent-2-en-1-yl]methyl}octa-1,6-dien-3-yl]oxy}phenyl)acetate

C29H38O5 (466.2719)


   

6,7-dihydroxy-n-(2-hydroxy-6-isopropyl-3,4,7-trimethyl-5,8-dioxo-1,4,7-triazacyclododec-1-en-9-yl)octa-2,4-dienamide

6,7-dihydroxy-n-(2-hydroxy-6-isopropyl-3,4,7-trimethyl-5,8-dioxo-1,4,7-triazacyclododec-1-en-9-yl)octa-2,4-dienamide

C23H38N4O6 (466.2791)


   

n-[(4z,7r,8z)-4-(chloromethylidene)-10-[(2s)-3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

n-[(4z,7r,8z)-4-(chloromethylidene)-10-[(2s)-3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

C25H39ClN2O4 (466.2598)


   

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H38O5 (466.2719)


   

(2s,3z,12bs)-3-ethylidene-9-methoxy-2-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2s,3z,12bs)-3-ethylidene-9-methoxy-2-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C30H34N4O (466.2732)


   

(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl tetradecanoate

(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl tetradecanoate

C29H38O5 (466.2719)


   

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-11-ol

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-11-ol

C30H34N4O (466.2732)


   

(2r,4as,6as,12br,14as,14br)-11-hydroxy-9-(hydroxymethyl)-10-methoxy-2,4a,6a,12b,14a-pentamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

(2r,4as,6as,12br,14as,14br)-11-hydroxy-9-(hydroxymethyl)-10-methoxy-2,4a,6a,12b,14a-pentamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C29H38O5 (466.2719)


   

(2r,4ar,5r,8as)-1,1,4a-trimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-2-yl 3-methylbutanoate

(2r,4ar,5r,8as)-1,1,4a-trimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-2-yl 3-methylbutanoate

C29H38O5 (466.2719)


   

1-{3,4-dihydroxy-5-[({3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl}oxy)methyl]oxolan-2-yl}-4-hydroxy-5,6-dihydropyrimidin-2-one

1-{3,4-dihydroxy-5-[({3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl}oxy)methyl]oxolan-2-yl}-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)


   

(1s,2s,4s,5r,6s,11r,14r,15s,18s,22r,23r)-9-hydroxy-6,10,14,15,22-pentamethyl-21-methylidene-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacos-9-ene-8,25-dione

(1s,2s,4s,5r,6s,11r,14r,15s,18s,22r,23r)-9-hydroxy-6,10,14,15,22-pentamethyl-21-methylidene-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacos-9-ene-8,25-dione

C29H38O5 (466.2719)


   

7-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

7-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H38O5 (466.2719)


   

(1s,2s,4r,5s,10r,11s,14r,15r,18s)-15-[(1s)-1-[(2s)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-ene-9,13-dione

(1s,2s,4r,5s,10r,11s,14r,15r,18s)-15-[(1s)-1-[(2s)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-ene-9,13-dione

C29H38O5 (466.2719)


   

11-hydroxy-9-(hydroxymethyl)-10-methoxy-2,4a,6a,12b,14a-pentamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

11-hydroxy-9-(hydroxymethyl)-10-methoxy-2,4a,6a,12b,14a-pentamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C29H38O5 (466.2719)


   

(2s,3z,12br)-3-ethylidene-9-methoxy-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2s,3z,12br)-3-ethylidene-9-methoxy-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C30H34N4O (466.2732)


   

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-11-ol

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-11-ol

C30H34N4O (466.2732)


   

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-hydroxy-2,11,16-trimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-hydroxy-2,11,16-trimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one

C29H38O5 (466.2719)


   

n-[(4z,8z)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

n-[(4z,8z)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

C25H39ClN2O4 (466.2598)


   

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-[({3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl}oxy)methyl]oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-[({3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl}oxy)methyl]oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)


   

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)


   

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

C30H34N4O (466.2732)


   

(z)-(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

(z)-(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C29H38O5 (466.2719)


   

n-[(4z,8e)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

n-[(4z,8e)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

C25H39ClN2O4 (466.2598)


   

(2e,4e)-6,7-dihydroxy-n-[(3s,6s,9s)-2-hydroxy-6-isopropyl-3,4,7-trimethyl-5,8-dioxo-1,4,7-triazacyclododec-1-en-9-yl]octa-2,4-dienimidic acid

(2e,4e)-6,7-dihydroxy-n-[(3s,6s,9s)-2-hydroxy-6-isopropyl-3,4,7-trimethyl-5,8-dioxo-1,4,7-triazacyclododec-1-en-9-yl]octa-2,4-dienimidic acid

C23H38N4O6 (466.2791)


   

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2r,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2r,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H38O5 (466.2719)


   

1,1,4a-trimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-2-yl 3-methylbutanoate

1,1,4a-trimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-2-yl 3-methylbutanoate

C29H38O5 (466.2719)


   

10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

C29H38O5 (466.2719)


   

methyl (2r,4as,6as,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate

methyl (2r,4as,6as,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate

C29H38O5 (466.2719)


   

1-[(2r,3s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

1-[(2r,3s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)


   

(6s,7r,10e)-6-hydroxy-2,6,10-trimethyl-13-(7-methyl-5,8-dioxonaphthalen-2-yl)trideca-2,10-dien-7-yl acetate

(6s,7r,10e)-6-hydroxy-2,6,10-trimethyl-13-(7-methyl-5,8-dioxonaphthalen-2-yl)trideca-2,10-dien-7-yl acetate

C29H38O5 (466.2719)


   

(2s,3z,12bs)-3-ethylidene-9-methoxy-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(2s,3z,12bs)-3-ethylidene-9-methoxy-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C30H34N4O (466.2732)


   

4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl tetradecanoate

4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl tetradecanoate

C29H38O5 (466.2719)


   

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

C30H34N4O (466.2732)


   

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

C30H34N4O (466.2732)


   

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

C30H34N4O (466.2732)


   

(1s,2r,6s,7r,9r,11s,12s,16s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,11,16-trimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one

(1s,2r,6s,7r,9r,11s,12s,16s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,11,16-trimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one

C29H38O5 (466.2719)


   

(e)-(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(e)-(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C29H38O5 (466.2719)


   

n-[(4z,7r,8e)-4-(chloromethylidene)-10-[(2s)-3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

n-[(4z,7r,8e)-4-(chloromethylidene)-10-[(2s)-3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

C25H39ClN2O4 (466.2598)


   

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)


   

9-hydroxy-6,10,14,15,22-pentamethyl-21-methylidene-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacos-9-ene-8,25-dione

9-hydroxy-6,10,14,15,22-pentamethyl-21-methylidene-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacos-9-ene-8,25-dione

C29H38O5 (466.2719)


   

methyl 10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate

methyl 10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate

C29H38O5 (466.2719)


   

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-ene-9,13-dione

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-ene-9,13-dione

C29H38O5 (466.2719)


   

n-{1-[(2r,5s,6r)-5-{[(4s,5s,6r)-5-(dimethylamino)-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-3-methylbutanamide

n-{1-[(2r,5s,6r)-5-{[(4s,5s,6r)-5-(dimethylamino)-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-3-methylbutanamide

C23H38N4O6 (466.2791)